Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by University of Vermont.
Recruitment status was  Recruiting
Cancer and Leukemia Group B
Information provided by (Responsible Party):
Steven Grunberg, University of Vermont Identifier:
First received: March 8, 2011
Last updated: January 23, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)